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Abstract
Background: Prehypertension and prediabetes are major risk factors of cardiovascular disease, and their combined
presence may result in more serious cardiovascular outcomes than expected with either prehypertension or
prediabetes alone. The aim of the present study was to evaluate the prevalence of coexisting prehypertension and
prediabetes, and the associated risk profiles in a Chinese population.
Methods: A cross-sectional survey in a representative sample of 3,595 men and 4,593 women aged 18 years and
older was performed between 2008 and 2010. Prehypertension and prediabetes were diagnosed using the
guidelines from the Seventh Report of the Joint National Committee on prevention, detection, and treatment of
high blood pressure and American Diabetes Association, respectively. Prehypertension was defined as a systolic
blood pressure of 120-139 mmHg and/or diastolic blood pressure of 80-89 mmHg, and prediabetes was defined as
a fasting blood glucose of 5.6-6.9 mmol/L.
Results: The prevalence of coexisting prehypertension and prediabetes was 11.0%. Men had a higher prevalence
of coexisting prehypertension and prediabetes than women (14.2% vs. 8.4%; P < 0.0001). This prevalence increased
with age and body mass index, and was the lowest among Mongolian-Chinese (5.1%). A multivariate analysis
showed that g-glutamyltransferase and uric acid were significantly and positively correlated with body mass index,
waist circumference, blood pressure, triglycerides, and total cholesterol, and negatively correlated with high density
lipoprotein cholesterol in subjects with prehypertension and prediabetes.
Conclusions: There is a large proportion of Chinese adults with coexisting prehypertension and prediabetes. Thus,
there is a need for more efforts that implement public health programs that target the earlier stages of
hypertension and diabetes.
Background
Cardiovascular disease (CVD) is considered to be a
major cause of death in most developed and developing
countries [1]. Hypertension is a major risk factor of
CVD. Even a slightly elevated blood pressure within the
normal range is associated with cardiovascular morbidity
and mortality [2]. Therefore, in 2003, the Seventh
Report of the Joint National Committee on the
Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure (JNC-7) introduced a new category:
prehypertension (PreHTN), where systolic blood pres-
sure (SBP) is from 120 to 139 mmHg, and/or diastolic
blood pressure (DBP) is from 80 to 89 mmHg [3]. Indi-
viduals with PreHTN are more susceptible to developing
true hypertension and coronary atherosclerosis [4]. Sev-
eral national blood pressure surveys in the United States
and other countries report that more than 30% of the
general adult population has PreHTN [5,6]. Prediabetes
(PreDM) is another important risk factor of CVD, which
is associated with impaired fasting glucose (IFG) and/or
glucose tolerance (IGT). According to the American
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serum glucose concentrations range from 5.6 mmol/L
(100 mg/dl) to 6.9 mmol/L (125 mg/dl), as well as IGT,
where serum glucose concentrations range from 7.8
mmol/L (140 mg/dl) to 11.1 mmol/L (199 mg/dl) 2 h
after a 75 g oral glucose load [7]. IFG is associated with
insulin resistance and an increased risk of cardiovascular
pathology. Although less risky than IGT, IFG is coupled
with a greater conversion from PreDM to overt diabetes
(i.e. approximately 24% in less than three years) [8].
Recently published data on a large population-based
sample of more than 45,000 people, aged 20 years and
older, in China indicated that the prevalence of PreDM
was 15.5% [9].
Given that the effects of certain clinical precursors, such
as PreHTN and PreDM, on the cardiovascular system are
often distinct, their combined presence in the same patient
m a yr e s u l ti nm o r es e v e r ec o r o n a r ya r t e r yd i s e a s et h a n
expected with either PreHTN or PreDM alone [10]. The
probable CVD risk with PreHTN and PreDM, to some
extent, is dependent on whether PreHTN leads to hyper-
tension and PreDM leads to diabetes. Additionally, racial
and ethnic differences are known to influence the preva-
lence and risks of PreHTN and PreDM [11,12]. Several
large surveys have yielded prevalence estimates for either
PreHTN or PreDM in China [9,13]. Nevertheless, there is
little information available in the literature regarding the
prevalence of coexisting PreHTN and PreDM (co-PreHTN
and PreDM) among individuals located in areas inhabited
by Chinese ethnic minorities. Furthermore, to the best of
our knowledge, there have been no population-based,
cross-sectional studies that have assessed the epidemiology
of co-PreHTN and PreDM among healthy Chinese adults.
Thus, the aim of the present study was to evaluate the pre-
valence of co-PreHTN and PreDM, along with their asso-
ciated risks, in populations located in northern and
northeastern China.
Methods
Study population
A population-based, cross-sectional survey of the Chinese
Physiological Constant and Health Condition (CPCHC)
was conducted between 2008 and 2010. Representative
samples of the general Chinese population, aged 18 years
and older, from the Hei Longjiang Province and Inner
Mongolian Autonomous Region in mainland China were
determined according to a random, multistage cluster
sampling scheme, allowing for good prevalence estimates
of the Chinese population. Two urban and two rural areas
were selected from each province. Written informed con-
sent was obtained from each participant prior to data col-
lection. The protocol was approved by the Institutional
Review Board of the Institute of Basic Medical Sciences,
Chinese Academy of Medical Sciences. Trained medical
personnel collected information on risk factors via ques-
tionnaires (e.g. demographic, socioeconomic, and health-
related information), and obtaining anthropometric mea-
surements and blood samples for biochemical
assessments.
Inclusions and exclusions
The 2008-2010 CPCHC samples included 29,639 appar-
ently healthy participants. Those who suffered from sys-
temic disease involving diabetes mellitus, hypertension or
other cardiovascular, renal, gastro-intestinal, pulmonary
disease or cancer were excluded. Moreover, participants
taking any medication known to affect carbohydrate and
lipid metabolism were also excluded. A schematic of the
screening process is presented in Figure 1. Of the total
number of participants, 44.3% (n = 13,140) were selected
randomly to complete blood testing. Of 8,475 adults,
aged ≥18 years, 287 (3.4%) had missing data on blood
pressure (BP) and/or laboratory tests. Therefore, the final
sample size of disease-free healthy adults was 8,188
(3,595 men and 4,593 women), of which 5,788 were Han
Chinese, 936 were Korean-Chinese, 1,237 were Mongo-
lian-Chinese, and 227 were of other ethnicity. Their age
distribution was as follows: 3,214 were aged 18-39 years,
1,762 were aged 40-49 years, 1,580 were aged 50-59
years, and 1,632 were aged > 60 years.
Data collection and anthropometry
Epidemiological data were collected on all subjects via a
standard questionnaire, which included demographic char-
acteristics (i.e. age, gender, and ethnicity), socioeconomic
data (i.e. educational level, marital status, and occupation),
past history, and lifestyle risk factors. Smoking status was
classified as non-smokers, current smokers (i.e. daily
smoking regardless of the amount and type), and ex-smo-
kers. Alcohol drinking status was defined as non-drinkers,
current drinkers (frequent consumption of alcohol regard-
less of the amount and type), and ex-drinkers.
Body weight was measured to the nearest 0.1 kg on a
calibrated beam scale and height was measured barefoot
in triplicate using a wall-mounted stadiometer to the near-
est 0.1 cm. Body mass index (BMI; an index of overall obe-
sity) was calculated as body weight (in kilograms) divided
by height (in meters squared). BMI was categorized
according to the World Health Organization criteria,
where a BMI of < 25 kg/m
2 is considered normal, a BMI
between 25 and 29 kg/m
2 is considered overweight, and a
BMI ≥30 kg/m
2 is considered obese [14]. Waist circumfer-
ence (WC; a surrogate marker for central adiposity) was
measured midway between the lower rib margin and the
iliac crest at the end of a gentle expiration.
BP was measured following a resting period of at least
10 min using an electronic sphygmomanometer
(OMRON, HEM-7000). The participant’s arm was placed
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times. The averages of the three measurements were
used. If a subject was hypertensive, then a review was
performed by doctors to exclude secondary hypertension.
Laboratory measurements
All procedures were performed following a 12-h over-
night fast. Blood was drawn from the antecubital vein of
the right arm. Serum g-glutamyltransferase (GGT; a sen-
sitive marker of alcohol intake and hepatic inflamma-
t i o n )a n du r i ca c i d( U A ;am a rker of inflammation and
metabolic syndrome), both of which play important
roles in the development of cardiovascular events, were
assayed with an Olympus AU2700 Automatic Biochem-
ical Analyzer and Olympus agent (Olympus, Tokyo,
Japan). Fasting blood glucose and lipid profiles, includ-
ing total cholesterol (TC), triglycerides (TG), high-den-
sity lipoprotein cholesterol (HDL-C), and low-density
lipoprotein cholesterol (LDL-C) were also assessed. The
biochemical laboratories participating in the survey fol-
lowed the same internal quality control program that
was standardized by the Peking Union Medical College
Hospital.
Diagnosis and classification of diabetes and hypertension
Diagnosis of PreHTN was based on the criteria in the
JNC-7 report [3]. Specifically, PreHTN was defined as a
SBP of 120-139 mmHg and/or a DBP of 80-89 mmHg,
whereas normotension was defined as a SBP < 120 mmHg
and a DBP < 80 mmHg, and hypertension was defined as
aS B P≥140 mmHg and/or a DBP ≥90 mmHg.
Diagnosis of PreDM was based on the criteria of the
American Diabetes Association [7]. Pre-DM was defined
as fasting blood glucose (FBG) levels from 100 mg/dl (5.6
mmol/L) to 125 mg/dl (6.9 mmol/L)], which indicated
IFG, and/or 2-h postprandial blood glucose (PBG) levels
from 140 mg/dl (7.8 mmol/L) to 199 mg/dl (11.1 mmol/L)
following a 75 g oral glucose load, which indicated IGT.
Individuals with FBG < 5.6 mmol/L were considered nor-
mal, whereas individuals with FBG ≥7.0 or 2-h PBG ≥11.1
were diagnosed with diabetes. Fasting was defined as no
caloric intake for at least 8 h.
Statistical analysis
Data were entered and documented on EpiData 3.1 soft-
ware (The EpiData Association, Odense, Denmark). Data-
sets were transferred into an SPSS compatible format.
Figure 1 A schematic used for screening and inclusion of the study sample. A total of 29,639 disease-free and healthy individuals were
recruited between 2008 and 2010, and 13,140 individuals had biochemistry measurements collected. Of the 8,475 adults aged ≥18 years, 287
participants had missing data on BP and/or laboratory tests, and as result were excluded. The final sample size was 8,188, which consisted of
2,340 individuals with both normotension and normoglycemia, 897 individuals with coexisting prehypertension and prediabetes, and 160
individuals with both hypertension and diabetes. Abbreviations: BP, blood pressure; FBG, fasting blood glucose; PreHTN, prehypertension; PreDM,
prediabetes; HTN, hypertension; DM, diabetes mellitus.
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errors (SE) for categorical variables, and means ± standard
deviation (SD) for continuous variables with a normal
distribution. Comparisons between groups were made
using an analysis of covariance. Medians and interquartile
ranges of GGT and TG were calculated due to their
abnormal distributions, and comparisons between these
groups were made using the Wilcoxon rank sum test. Pre-
valence (%) indicates the percentage of healthy Chinese
men and women with a condition at the time of data col-
lection, and means indicate the average value of a charac-
teristic in healthy Chinese adults. Correlation analyses
were performed using either the Pearson or Spearman
correlations. Statistical analyses were performed on the
statistical software, SPSS version 13.0 (SPSS Inc., Chicago,
Illinois, USA). All tests for statistical significance were
two-tailed, and considered significant when P <0 . 0 5 .
Results
Epidemiology
Of the 8,188 disease-free adults, 897 (11.0 ± 0.3%) had co-
PreHTN and PreDM, 160 (2.0 ± 0.2%) had concurrent
hypertension and diabetes mellitus, 2,340 (28.6 ± 0.5%)
had both normotension and normoglycemia, and the
remaining 4,791 had other combinations of resting BP and
fasting serum glucose concentrations as shown in Table 1.
The prevalence of co-PreHTN and PreDM was higher
in the Hei Longjiang province compared to the Inner
Mongolian Autonomous Region (13.3% vs. 8.8%, P <
0.0001), as shown in Table 2. Men had a higher preva-
lence of co-PreHTN and PreDM than women (14.2% vs.
8.4%, P < 0.0001). The prevalence increased with age (i.e.
6.6% for those 18-39 years old, 11.6% for those 40-49
years old, 14.0% for those 50-59 years old, and 15.9% for
those > 60 years old) and BMI (i.e. 6.0% for those with a
BMI < 18.5 kg/m
2, 9.1% for those with a BMI between
18.5 and 24.9 kg/m
2, 14.7% for those with a BMI between
25 and 29.9 kg/m
2, and 12.5% for those with a BMI ≥30
kg/m
2). Mongolian-Chinese (5.1%) had the lowest preva-
lence of co-PreHTN and PreDM, whereas both the Han-
Chinese (12.0%) and Korean-Chinese (11.6%) demon-
strated a two-fold greater risk of co-PreHTN and PreDM
than the Mongolian-Chinese. Furthermore, those with a
lower educational level, such as primary or secondary
education, tended to have a higher prevalence of co-
PreHTN and PreDM. Co-PreHTN and PreDM partici-
p a n t sw e r em o r el i k e l yt ob em a r r i e d ,e x - s m o k i n g ,a n d
current alcohol drinkers (P < 0.0001).
Cardiometabolic risk profile
A summary of the cardiometabolic risk factors of the
study population are presented in Table 3, according to
their cardiometabolic status (i.e. normotensive and normo-
glycemic, prehypertensive and prediabetic, or hypertensive
and diabetic). SBP (108.9 ± 7.2, 126.3 ± 6.9, 148.9 ± 15.6
mmHg, respectively) and DBP (70.1 ± 6.0, 80.4 ± 5.7, 91.8
± 10.1 mmHg, respectively; P < 0.0001) increased gradu-
ally across these categories. Furthermore, there was a
steady increase in BMI and WC in both men and women
with increasing BP and impaired glucose metabolism.
Compared to the normotensive and normoglycemic
group, the co-PreHTN and PreDM group had a signifi-
cantly higher GGT (28.6 [18.0-48.9] U/L), UA (333.4 ±
86.4 μmol/L), and fasting serum glucose (6.0 ± 0.3 mmol/
L; P < 0.0001). With respect to the fasting lipid profiles,
both TG and TC were significantly lower in normotensive
and normoglycemic individuals compared to those with
co-PreHTN and PreDM (both P < 0.0001). Additionally,
atherogenic LDL-C was significantly lower, whereas anti-
atherogenic HDL-C was significantly higher (both P <
0.0001) in normotensive and normoglycemic individuals
versus those with co-PreHTN and PreDM.
Table 4 demonstrates the correlations between BMI, BP,
GLU, and lipid profiles with GGT and UA in individuals
with co-PreHTN and PreDM. A multivariate correlation
analysis demonstrated that GGT and UA levels were sig-
nificantly and positively associated with BMI, WC, and
SBP in the subjects with co-PreHTN and PreDM. Addi-
tionally, a significant and positive correlation was observed
between serum TG and GGT/UA. Interestingly, a negative
correlation was observed between both GGT and UA with
HDL-C. A significant positive correlation was also
observed between TC and GGT/UA.
Discussion
In the present study, the population studied presents a
high prevalence of co-PreHTN and PreDM in appar-
ently healthy Chinese adults. The prevalence of co-
Table 1 Number of disease-free adults categorized by resting blood pressure and serum glucose levels
Resting blood pressure
Fasting blood glucose Normal Prehypertension Hypertension (SBP &DBP) Total
(< 120/80 mmHg) (120-139/80-89 mmHg) (≥ 140/90 mmHg)
Normal (< 5.6 mmol/L) 2340 2625 1057 6022
Prediabetes (5.6 - 6.9 mmol/L) 375 897 498 1770
Diabetes (≥ 7.0 mmol/L) 40 196 160 396
Total 2755 3718 1715 8188
Sample population was classified by blood pressure and glucose status.
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women, and increased with age and BMI. Our findings
suggest that prevalence of co-PreHTN and PreDM in
our population is similar to that observed in a recent
survey conducted in a healthy US population [15]. It has
been previously reported that PreDM markedly
increases CVD risk in prehypertensive individuals [16].
The recent findings of the Strong Heart Study also
revealed that in non-diabetic individuals, IFG and
PreHTN increases the number of cardiovascular events
by 2.06-fold compared to their normotensive and nor-
moglycemic counterparts, with an absolute increase of 5
cardiovascular events per 1000 person years [10].
It has also been previously shown that there are
marked ethnic and geographic differences in BP and FBG
levels in China [9,17]. Living conditions, habitual diets,
and social circumstances in disparate communities also
exhibit different characteristics. In the present study, the
prevalence of co-PreHTN and PreDM was higher in the
Hei Longjiang province of northern China compared to
the Inner Mongolian Autonomous Region in northeast-
ern China (13.3% versus 8.8%). There are a number of
potential factors that may contribute to these differences.
For example, there are more people in the Hei Longjiang
province that are overweight or obese, dyslipidemic, and
have a higher salt intake [18]. Unfortunately, data on
Table 2 Prevalence (%) of healthy Chinese adults with either normotension and normoglycemia, prehypertension and
prediabetes, or hypertension and diabetes mellitus
Normotension and Normoglycemia PreHTN and PreDM HPT and DM
N Prevalence N Prevalence N Prevalence
(%) (%) (%)
Overall (2008-2010) 2340 28.6 ± 0.5 897 11.0 ± 0.3 160 2.0 ± 0.2
Survey area
Hei Longjiang province 1137 29.3 ± 0.6 519 13.3 ± 0.5 97 2.5 ± 0.3
Inner Mongolian Autonomous Region 1203 27.9 ± 0.7 378 8.8 ± 0.4 63 1.5 ± 0.2
Gender
Men 645 17.9 ± 0.6 512 14.2 ± 0.6 98 2.7 ± 0.3
Women 1695 36.9 ± 0.7 385 8.4 ± 0.4 62 1.3 ± 0.2
Age group (years)
18-39 1438 44.7 ± 0.8 212 6.6 ± 0.4 7 0.2 ± 0.1
40-49 495 28.1 ± 1.1 205 11.6 ± 0.8 30 1.7 ± 0.3
50-59 268 17.0 ± 0.9 221 14.0 ± 0.9 42 2.7 ± 0.4
60- 139 8.5 ± 0.7 259 15.9 ± 0.9 81 5.0 ± 0.5
Ethnic group
Han 1662 28.7 ± 0.6 695 12.0 ± 0.4 112 1.9 ± 0.2
Korean 195 20.8 ± 1.3 109 11.6 ± 1.0 34 3.6 ± 0.6
Mongolian 395 31.9 ± 1.3 63 5.1 ± 0.6 10 0.8 ± 0.3
Other 88 38.8 ± 3.2 30 13.2 ± 2.2 4 1.7 ± 0.8
Education
Primary or below 119 14.5 ± 1.2 100 12.2 ± 1.1 69 8.4 ± 1.0
Secondary 874 24.3 ± 0.7 461 12.8 ± 0.6 48 1.3 ± 0.2
Matriculation or above 1307 36.1 ± 0.8 320 8.8 ± 0.5 42 1.2 ± 0.2
Marital status
Married 1471 25.1 ± 0.6 724 12.4 ± 0.4 132 2.3 ± 0.2
Single 677 50.9 ± 1.3 51 3.8 ± 0.5 3 0.2 ± 0.1
Divorced/widowed 85 19.3 ± 1.9 51 11.6 ± 1.5 14 3.2 ± 0.8
Smoking
Non-smoker 1886 32.2 ± 0.6 561 9.6 ± 0.4 110 1.9 ± 0.2
Current smoker 357 20.1 ± 0.9 242 13.6 ± 0.8 35 2.0 ± 0.3
Ex-smoker 49 15.0 ± 2.0 55 16.8 ± 2.1 13 4.0 ± 1.1
Alcohol consumption
Non-drinker 1825 32.6 ± 0.6 540 9.6 ± 0.4 93 1.7 ± 0.2
Current drinker 413 19.4 ± 0.9 290 13.6 ± 0.7 57 2.7 ± 0.3
Ex-drinker 38 19.5 ± 2.8 24 12.3 ± 2.3 8 4.1 ± 1.4
1Percent prevalence ± standard error.
2Abbreviations: PreHTN, prehypertension; PreDM, prediabetes; HPT, hypertension; DM, diabetes mellitus.
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study. Furthermore, based on the regional differences,
there may be genetic contributions to the co-PreHTN
and PreDM phenotype that should also be considered.
There was a higher prevalence of co-PreHTN and
PreDM among individuals that consumed alcohol and
smoked. This finding was consistent with earlier studies,
which found that excessive alcohol consumption and
cigarette smoking increase BP and glucose levels [19,20].
Interestingly, we also found that there was higher preva-
lence of ex-smokers than current smokers in the co-
PreHTN and PreDM group. This observation can be
explained by the findings of Inoue K [21], who sug-
gested that the adverse effects associated with the
weight gain following cessation of smoking outweigh the
benefits. Weight gain is a strong risk factor for CVD,
which is also closely associated with a substantial risk
for impaired glucose regulation and elevated BP [22].
In the present study, we also observed that, with the
exception of HDL-C, the lipid profile and glucose levels
demonstrated a gradual upward trend from the normoten-
sive and normoglycemic group, followed by the co-
PreHTN and PreDM group, and lastly the hypertensive
and diabetic group. In addition to the larger WC and BMI,
our findings also suggest that these considerably “healthy”
men and women are at an increased risk for CVD. Other
biochemical parameters, such as GGT and UA levels, were
also relatively higher in subjects with co-PreHTN and
PreDM. Recent cross-sectional and longitudinal studies
have also noted a relatively independent association
between elevated serum GGT levels, and hypertension and
diabetes [23,24]. We have also revealed that higher serum
GGT levels are positively associated with PreHTN in an
otherwise healthy Chinese adult population following var-
ious adjustments in the multivariate logistic regression
analysis (unpublished observations). In addition, a recent
Table 3 A comparison of select age-adjusted cardiovascular risk factors in individuals with normotension and
normoglycemia, prehypertension and prediabetes, and hypertension and diabetes
Normotension-normoglycemia Prehypertension-prediabetes Hypertension-diabetes
N x ± s/M(QR) N x ± s/M(QR) N x ± s/M(QR) P-value
a P-value
b
BMI (kg/m
2)
Men 645 22.5 ± 3.2 512 25.4 ± 3.5 96 26.6 ± 3.1 < 0.0001 0.0018
Women 1692 22.2 ± 3.9 384 24.6 ± 3.2 61 26.8 ± 3.7 < 0.0001 < 0.0001
WC (cm)
Men 628 79.0 ± 9.7 498 88.1 ± 9.3 97 92.2 ± 8.5 < 0.0001 < 0.0001
Women 1654 73.3 ± 8.3 376 82.0 ± 8.8 60 88.7 ± 9.8 < 0.0001 < 0.0001
SBP (mmHg) 2430 108.9 ± 7.2 897 126.3 ± 6.9 160 148.9 ± 15.6 < 0.0001 < 0.0001
DBP (mmHg) 2430 70.1 ± 6.0 897 80.4 ± 5.7 160 91.8 ± 10.1 < 0.0001 < 0.0001
GGT (U/L) 2339 15.4 (12.0-22.9) 897 28.6(18.0-48.9) 160 38.1(25.0-64.0) < 0.0001 < 0.0001
UA (μmol/L) 2339 274.9 ± 74.6 897 333.4 ± 86.4 160 321.3 ± 78.3 < 0.0001 0.0984
GLU (mmol/L) 2340 5.0 ± 0.4 897 6.0 ± 0.3 160 9.1 ± 2.5 < 0.0001 < 0.0001
TG (mmol/L) 2340 0.97(0.73-1.35) 897 1.58(1.08-2.35) 160 2.22(1.52-3.25) < 0.0001 < 0.0001
TC (mmol/L) 2340 4.4 ± 0.9 897 5.0 ± 1.1 160 5.3 ± 1.1 < 0.0001 0.0015
HDL-C (mmol/L) 2334 1.5 ± 0.3 895 1.4 ± 0.4 160 1.3 ± 0.3 < 0.0001 0.0026
LDL-C (mmol/L) 2340 2.3 ± 0.8 897 2.8 ± 0.9 160 3.1 ± 0.9 < 0.0001 0.0001
1GGT and TG were reported as medians (interquartile range).
2Age-adjusted by analysis of covariance.
3Abbreviations: BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; GGT, g- glutamyltransferase; UA, uric
acid; GLU, glucose; TG, triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.
a Normotension-normoglycemia vs. prehypertension-prediabetes
b Prehypertension-prediabetes vs. hypertension-diabetes
Table 4 Correlations between various relevant factors
and serum GGT and UA in prehypertensive and
prediabetic individuals
Parameters GGT UA
r p r p
BMI 0.375 0.000 0.289 0.000
WC 0.434 0.000 0.405 0.000
SBP 0.041 0.215 0.074 0.026
DBP 0.148 0.000 0.071 0.333
GLU 0.169 0.000 0.041 0.215
TG 0.454 0.000 0.316 0.000
TC 0.251 0.000 0.139 0.000
HDL-C -0.206 0.000 -0.236 0.000
LDL-C 0.167 0.000 0.047 0.157
Abbreviations: GGT, g- glutamyltransferase; UA, uric acid; BMI, body mass
index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic
blood pressure; GLU, glucose; TG, triglyceride; TC, total cholesterol; HDL-C,
high density lipoprotein cholesterol; LDL-C, low density lipoprotein
cholesterol.
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associated with the presence of the IFG, further supporting
our conclusion. Similarly, serum UA levels correlated with
metabolic abnormalities and CVD [26]. A previous study
[27] found that there is a significant association between
serum UA levels and the risk of PreHTN. Meanwhile, in
the Rancho Bernardo Study, it was suggested that UA may
be a useful predictor of type 2 diabetes in older adults
with IFG [28]. However, the underlying mechanisms for
higher GGT and UA in subjects with co-PreHTN and
PreDM are unclear and require further clarification.
A major strength of our study is that it is a popula-
tion-based study with a good representative sample of
the general Chinese population. Additionally, the larger
sample size ensures sufficient power in estimating the
prevalence of co-PreHTN and PreDM, as well as deter-
mining the correlation between co-PreHTN and PreDM,
and CVD risk factors. Lastly, the use of standardized
protocols and instruments guaranteed a high response
rate and excellent quality control.
However, the study also has several limitations. First,
oral glucose tolerance test (OGTT) was not performed in
subjects with IFG, thereby potentially reducing the accu-
rate diagnosis of diabetes. Since some individuals with
normal FBG may have IGT, based on OGTT data, exam-
ining FBG alone (i.e. without a 2-h PBG) may result in the
underestimating of the prevalence of co-PreHTN and
PreDM in healthy Chinese adults. Lastly, the study is
based on a cross-sectional survey, which is unable to
determine causality or the temporal relationship between
CVD risk factors and co-PreHTN and PreDM.
Conclusions
Our data highlights the high prevalence of co-PreHTN and
PreDM in disease-free Chinese adults from northern and
northeastern China. With the exception of HDL-C, higher
lipid profile levels, as well as GGT, UA, and FBG, in co-
PreHTN and PreDM individuals may have important
pathophysiological implications. All of these changes have
been shown to increase CVD risk, and thereby suggests
that there is an urgent need for early detection and appro-
priate interventions. A healthy lifestyle, such as weight con-
trol, increased physical activity, moderate alcohol intake,
tobacco cessation, salt reduction, and sufficient consump-
tion of fresh fruits and vegetables could prevent the pro-
gression of co-PreHTN and PreDM to overt hypertension
and diabetes mellitus. Public health programs are required
to improve this situation in the Chinese population.
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